MY193895A - Combination test for colorectal cancer - Google Patents
Combination test for colorectal cancerInfo
- Publication number
- MY193895A MY193895A MYPI2019000398A MYPI2019000398A MY193895A MY 193895 A MY193895 A MY 193895A MY PI2019000398 A MYPI2019000398 A MY PI2019000398A MY PI2019000398 A MYPI2019000398 A MY PI2019000398A MY 193895 A MY193895 A MY 193895A
- Authority
- MY
- Malaysia
- Prior art keywords
- colorectal cancer
- combination test
- patient
- methods
- colorectal
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1612815.9A GB201612815D0 (en) | 2016-07-25 | 2016-07-25 | Novel combination test |
| PCT/EP2017/068754 WO2018019827A1 (en) | 2016-07-25 | 2017-07-25 | Combination test for colorectal cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY193895A true MY193895A (en) | 2022-10-31 |
Family
ID=56894403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2019000398A MY193895A (en) | 2016-07-25 | 2017-07-25 | Combination test for colorectal cancer |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20200182875A1 (https=) |
| EP (1) | EP3488238B1 (https=) |
| JP (1) | JP6983221B2 (https=) |
| KR (1) | KR102442803B1 (https=) |
| CN (1) | CN109791154A (https=) |
| AU (1) | AU2017301970B2 (https=) |
| BR (1) | BR112019001384A2 (https=) |
| CA (1) | CA3031580A1 (https=) |
| GB (1) | GB201612815D0 (https=) |
| IL (1) | IL264359B2 (https=) |
| MY (1) | MY193895A (https=) |
| RU (1) | RU2019104870A (https=) |
| SG (2) | SG10202100630SA (https=) |
| TW (1) | TWI776816B (https=) |
| WO (1) | WO2018019827A1 (https=) |
| ZA (1) | ZA201808601B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201906199D0 (en) * | 2019-05-02 | 2019-06-19 | Belgian Volition Sprl | Method for the detection of cancer |
| WO2021024009A1 (en) * | 2019-08-02 | 2021-02-11 | Shanghai Yunxiang Medical Technology Co., Ltd. | Methods and compositions for providing colon cancer assessment using protein biomarkers |
| CN112345766B (zh) * | 2020-10-22 | 2024-02-02 | 中国工程物理研究院核物理与化学研究所 | 一种荧光-放射性联用的体外靶向筛选方法 |
| TW202242146A (zh) * | 2021-01-13 | 2022-11-01 | 比利時商比利時意志有限公司 | 肺癌的檢測方法 |
| EP4291899A1 (en) * | 2021-02-11 | 2023-12-20 | EDP Biotech Corporation | Kits and methods for detecting markers and determining the presence or risk of cancer |
| WO2024223947A1 (en) * | 2023-04-28 | 2024-10-31 | Belgian Volition Srl | Use of cell free nucleosomes as biomarkers of carcinomas |
| CN116973572B (zh) * | 2023-06-02 | 2025-03-07 | 东南大学附属中大医院 | 基于血、粪便铁蛋白检测评估肠屏障损伤严重程度的方法 |
| CN116718775B (zh) * | 2023-08-04 | 2023-10-27 | 天津迈基生物科技有限公司 | 一种检测结直肠癌的组合物、试纸及方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2541178T3 (es) * | 2009-02-03 | 2015-07-16 | Mdxhealth Sa | Método de detección de cáncer colorrectal |
| WO2010120942A2 (en) * | 2009-04-14 | 2010-10-21 | The Regents Of The University Of California | Histone modification patterns for clinical diagnosis and prognosis of cancer |
| US8568984B2 (en) * | 2010-02-19 | 2013-10-29 | Philadelphia Health & Education Corporation | Methods of diagnosing non-urinary tract diseases by detecting aberrant methylation |
| JP2012018119A (ja) * | 2010-07-09 | 2012-01-26 | Toray Ind Inc | 大腸癌検出用マーカーおよびそれを用いた大腸癌検出方法 |
| CN103328500B (zh) * | 2010-08-04 | 2018-01-26 | 西兹尔生物技术有限公司 | 用于癌症的诊断和治疗的方法和化合物 |
| GB201115098D0 (en) * | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| PT2788767T (pt) * | 2011-12-07 | 2017-12-06 | Belgian Volition Sprl | Método de detecção de adutos de nucleosoma |
| EP4001436B1 (en) * | 2012-05-11 | 2024-03-13 | Clinical Genomics Pty. Ltd. | Diagnostic gene marker panel |
-
2016
- 2016-07-25 GB GBGB1612815.9A patent/GB201612815D0/en not_active Ceased
-
2017
- 2017-07-25 RU RU2019104870A patent/RU2019104870A/ru unknown
- 2017-07-25 MY MYPI2019000398A patent/MY193895A/en unknown
- 2017-07-25 WO PCT/EP2017/068754 patent/WO2018019827A1/en not_active Ceased
- 2017-07-25 BR BR112019001384-9A patent/BR112019001384A2/pt not_active Application Discontinuation
- 2017-07-25 IL IL264359A patent/IL264359B2/en unknown
- 2017-07-25 TW TW106124811A patent/TWI776816B/zh active
- 2017-07-25 SG SG10202100630SA patent/SG10202100630SA/en unknown
- 2017-07-25 JP JP2019503672A patent/JP6983221B2/ja active Active
- 2017-07-25 SG SG11201900329XA patent/SG11201900329XA/en unknown
- 2017-07-25 CN CN201780045694.2A patent/CN109791154A/zh active Pending
- 2017-07-25 KR KR1020197002048A patent/KR102442803B1/ko active Active
- 2017-07-25 CA CA3031580A patent/CA3031580A1/en active Pending
- 2017-07-25 US US16/320,440 patent/US20200182875A1/en not_active Abandoned
- 2017-07-25 AU AU2017301970A patent/AU2017301970B2/en not_active Ceased
- 2017-07-25 EP EP17743043.6A patent/EP3488238B1/en active Active
-
2018
- 2018-12-20 ZA ZA2018/08601A patent/ZA201808601B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL264359B2 (en) | 2024-03-01 |
| EP3488238B1 (en) | 2023-06-07 |
| TW201804156A (zh) | 2018-02-01 |
| TWI776816B (zh) | 2022-09-11 |
| IL264359B1 (en) | 2023-11-01 |
| AU2017301970A1 (en) | 2019-01-17 |
| KR102442803B1 (ko) | 2022-09-15 |
| JP6983221B2 (ja) | 2021-12-17 |
| CN109791154A (zh) | 2019-05-21 |
| BR112019001384A2 (pt) | 2019-04-30 |
| US20200182875A1 (en) | 2020-06-11 |
| RU2019104870A (ru) | 2020-08-25 |
| IL264359A (en) | 2019-02-28 |
| EP3488238A1 (en) | 2019-05-29 |
| ZA201808601B (en) | 2019-09-25 |
| WO2018019827A1 (en) | 2018-02-01 |
| GB201612815D0 (en) | 2016-09-07 |
| EP3488238C0 (en) | 2023-06-07 |
| JP2019527361A (ja) | 2019-09-26 |
| SG11201900329XA (en) | 2019-02-27 |
| KR20190039089A (ko) | 2019-04-10 |
| AU2017301970B2 (en) | 2023-04-27 |
| RU2019104870A3 (https=) | 2020-12-01 |
| SG10202100630SA (en) | 2021-03-30 |
| CA3031580A1 (en) | 2018-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY193895A (en) | Combination test for colorectal cancer | |
| ZA202000935B (en) | Methods and materials for assessing and treating cancer | |
| CR20110567A (es) | Dispositivos para diagnostico y metodos relacionados | |
| EP4464797A3 (en) | Kit, device, and method for detecting lung cancer | |
| EP3640341A3 (en) | Assays to determine dna methylation and dna methylation markers of cancer | |
| WO2021222220A3 (en) | Rna markers and methods for identifying colon cell proliferative disorders | |
| BR112015022934A2 (pt) | esteroides neuroativos, composições, e uso do mesmo | |
| AR105618A1 (es) | Metilación del promotor del ligando al receptor de muerte programada (pd-l1) en cáncer | |
| EP3159695A3 (en) | Methods for diagnosing pancreatic cancer | |
| CR20190574A (es) | Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos | |
| MX2020006728A (es) | Metodos para medir analito y/o proteina en muestras biologicas. | |
| MX2018009254A (es) | Metodos para evaluar el riesgo de desarrollar cancer colorrectal. | |
| IL245766A0 (en) | Different levels in blood cell samples of emt markers for the diagnosis of cancer, in particular colon cancer (crc) and pancreatic cancer (pc) | |
| WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
| EA201691682A1 (ru) | Способы анализирования редких циркулирующих в крови клеток | |
| BR112018010764A2 (pt) | método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente | |
| WO2014100717A3 (en) | Compositions, methods and kits for diagnosis of lung cancer | |
| BR112016028838A2 (pt) | anticorpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de detecção de lgr5 humano em uma amostra biológica, de detecção de um câncer, de identificação de um paciente com câncer, de seleção de um paciente com câncer para tratamento com um imunoconjugado e de tratamento de um paciente com câncer | |
| WO2016118920A3 (en) | Metabolomic based biomarkers for colon cancer detection | |
| MX2019000591A (es) | Tira mejorada de ensayo de analisis de orina de bajo volumen de muestra, kits analiticos y metodos de uso relacionados con la misma. | |
| WO2012054824A3 (en) | Prognostic biomarkers in patients with ovarian cancer | |
| WO2014184684A3 (en) | Methods and biomarkers for detection of hematological cancers | |
| EP3236261A4 (en) | Test strip for use in immunochromatography for detecting analyte in sample containing red blood cells, and immunochromatography using said test strip | |
| CY1121482T1 (el) | Ευαισθητη πολυπλεκτικη ανοσοδοκιμασια για τους διαλυτους υποδοχεις των αυξητικων παραγοντων των ινοβλαστων | |
| EA202090439A1 (ru) | Способы и материалы для оценки и лечения рака |